The name of this superfamily has been modified since the most recent official CATH+ release (v4_3_0). At the point of the last release, this superfamily was named:
"Transferase(Phosphotransferase) domain 1
".
FunFam 99: Serine/threonine-protein kinase receptor
Please note: GO annotations are assigned to the full protein sequence rather than individual protein domains. Since a given protein can contain multiple domains, it is possible that some of the annotations below come from additional domains that occur in the same protein, but have been classified elsewhere in CATH.
There are 30 GO terms relating to "molecular function"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
BMP receptor activity GO:0098821
Combining with a member of the bone morphogenetic protein (BMP) family, and transmitting a signal across the plasma membrane to initiate a change in cell activity.
|
23 |
P27037 (/ISS)
P27037 (/ISS)
P27037 (/ISS)
P27037 (/ISS)
P27037 (/ISS)
P27037 (/ISS)
P27037 (/ISS)
P27037 (/ISS)
P27037 (/ISS)
P27037 (/ISS)
(13 more) |
Protein binding GO:0005515
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
|
21 |
P27037 (/IPI)
P27037 (/IPI)
P27037 (/IPI)
P27037 (/IPI)
P27037 (/IPI)
P27037 (/IPI)
P27037 (/IPI)
P27037 (/IPI)
P27037 (/IPI)
P27037 (/IPI)
(11 more) |
Protein serine/threonine kinase activity GO:0004674
Catalysis of the reactions: ATP + protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate.
|
16 |
P27037 (/EXP)
P27037 (/EXP)
P27037 (/EXP)
P27037 (/EXP)
P27037 (/EXP)
P27037 (/EXP)
P27037 (/EXP)
P27037 (/EXP)
P27037 (/EXP)
P27037 (/EXP)
(6 more) |
Transmembrane receptor protein serine/threonine kinase activity GO:0004675
Combining with a signal and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity by catalysis of the reaction: ATP protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate.
|
16 |
P27037 (/TAS)
P27037 (/TAS)
P27037 (/TAS)
P27037 (/TAS)
P27037 (/TAS)
P27037 (/TAS)
P27037 (/TAS)
P27037 (/TAS)
P27037 (/TAS)
P27037 (/TAS)
(6 more) |
Coreceptor activity GO:0015026
Combining with an extracellular or intracellular messenger, and in cooperation with a nearby primary receptor, initiating a change in cell activity.
|
14 |
P27037 (/IDA)
P27037 (/IDA)
P27037 (/IDA)
P27037 (/IDA)
P27037 (/IDA)
P27037 (/IDA)
P27037 (/IDA)
P27037 (/IDA)
P27037 (/IDA)
P27037 (/IDA)
(4 more) |
Activin binding GO:0048185
Interacting selectively and non-covalently with activin, a dimer of inhibin-beta subunits.
|
10 | A0A0B4KG59 (/IDA) P27040 (/IDA) P38444 (/IDA) P38445 (/IDA) Q24229 (/IDA) Q24468 (/IDA) Q90669 (/IDA) Q90669 (/IDA) Q90669 (/IDA) Q90670 (/IDA) |
Growth factor binding GO:0019838
Interacting selectively and non-covalently with any growth factor, proteins or polypeptides that stimulate a cell or organism to grow or proliferate.
|
7 | P27038 (/IPI) P27038 (/IPI) P27038 (/IPI) P27038 (/IPI) P27040 (/IPI) Q13705 (/IPI) Q13705 (/IPI) |
Protein serine/threonine kinase activity GO:0004674
Catalysis of the reactions: ATP + protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate.
|
5 | P27038 (/ISO) P27038 (/ISO) P27038 (/ISO) P27038 (/ISO) P27040 (/ISO) |
Growth factor binding GO:0019838
Interacting selectively and non-covalently with any growth factor, proteins or polypeptides that stimulate a cell or organism to grow or proliferate.
|
5 | P27038 (/IMP) P27038 (/IMP) P27038 (/IMP) P27038 (/IMP) P27040 (/IMP) |
Inhibin binding GO:0034711
Interacting selectively and non-covalently with an inhibin monomer, any of the polypeptides that combine to form activin and inhibin dimers.
|
5 | P27038 (/ISO) P27038 (/ISO) P27038 (/ISO) P27038 (/ISO) P27040 (/ISO) |
Activin binding GO:0048185
Interacting selectively and non-covalently with activin, a dimer of inhibin-beta subunits.
|
5 | F1NCI7 (/IMP) Q90669 (/IMP) Q90669 (/IMP) Q90669 (/IMP) Q90670 (/IMP) |
Activin binding GO:0048185
Interacting selectively and non-covalently with activin, a dimer of inhibin-beta subunits.
|
5 | P27038 (/IPI) P27038 (/IPI) P27038 (/IPI) P27038 (/IPI) P27040 (/IPI) |
Activin binding GO:0048185
Interacting selectively and non-covalently with activin, a dimer of inhibin-beta subunits.
|
5 | P27038 (/ISO) P27038 (/ISO) P27038 (/ISO) P27038 (/ISO) P27040 (/ISO) |
BMP receptor activity GO:0098821
Combining with a member of the bone morphogenetic protein (BMP) family, and transmitting a signal across the plasma membrane to initiate a change in cell activity.
|
5 | A0A0B4KG59 (/IMP) P27038 (/IMP) P27038 (/IMP) P27038 (/IMP) P27038 (/IMP) |
Protein serine/threonine kinase activity GO:0004674
Catalysis of the reactions: ATP + protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate.
|
4 | P27038 (/TAS) P27038 (/TAS) P27038 (/TAS) P27038 (/TAS) |
Coreceptor activity GO:0015026
Combining with an extracellular or intracellular messenger, and in cooperation with a nearby primary receptor, initiating a change in cell activity.
|
4 | P27038 (/ISO) P27038 (/ISO) P27038 (/ISO) P27038 (/ISO) |
PDZ domain binding GO:0030165
Interacting selectively and non-covalently with a PDZ domain of a protein, a domain found in diverse signaling proteins.
|
4 | P27038 (/IPI) P27038 (/IPI) P27038 (/IPI) P27038 (/IPI) |
Inhibin binding GO:0034711
Interacting selectively and non-covalently with an inhibin monomer, any of the polypeptides that combine to form activin and inhibin dimers.
|
4 | P27038 (/IPI) P27038 (/IPI) P27038 (/IPI) P27038 (/IPI) |
Protein self-association GO:0043621
Interacting selectively and non-covalently with a domain within the same polypeptide.
|
4 | P27038 (/IPI) P27038 (/IPI) P27038 (/IPI) P27038 (/IPI) |
Activin-activated receptor activity GO:0017002
Combining with activin and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity. Activin is one of two gonadal glycoproteins related to transforming growth factor beta.
|
3 | A0A0B4KG59 (/IDA) Q24229 (/IDA) Q24468 (/IDA) |
Protein serine/threonine kinase activity GO:0004674
Catalysis of the reactions: ATP + protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate.
|
2 | Q13705 (/IMP) Q13705 (/IMP) |
Inhibin binding GO:0034711
Interacting selectively and non-covalently with an inhibin monomer, any of the polypeptides that combine to form activin and inhibin dimers.
|
2 | P38444 (/IDA) P38445 (/IDA) |
Activin binding GO:0048185
Interacting selectively and non-covalently with activin, a dimer of inhibin-beta subunits.
|
2 | P38444 (/TAS) P38445 (/TAS) |
Protein serine/threonine kinase activity GO:0004674
Catalysis of the reactions: ATP + protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate.
|
1 | P27040 (/IDA) |
Protein serine/threonine/tyrosine kinase activity GO:0004712
Catalysis of the reactions: ATP + a protein serine = ADP + protein serine phosphate; ATP + a protein threonine = ADP + protein threonine phosphate; and ATP + a protein tyrosine = ADP + protein tyrosine phosphate.
|
1 | P27040 (/IDA) |
Transforming growth factor beta-activated receptor activity GO:0005024
Combining with a transforming growth factor beta (TGFbeta) and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity by catalysis of the reaction: ATP protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate.
|
1 | A0A0B4KG59 (/IGI) |
Activin receptor activity, type II GO:0016362
Combining with activin to initiate a change in cell activity; upon ligand binding, binds to and catalyses the phosphorylation of a type I activin receptor.
|
1 | A0A0B4KG59 (/IDA) |
Activin receptor activity, type II GO:0016362
Combining with activin to initiate a change in cell activity; upon ligand binding, binds to and catalyses the phosphorylation of a type I activin receptor.
|
1 | A0A0B4KG59 (/IMP) |
Growth factor binding GO:0019838
Interacting selectively and non-covalently with any growth factor, proteins or polypeptides that stimulate a cell or organism to grow or proliferate.
|
1 | P27040 (/ISO) |
BMP receptor activity GO:0098821
Combining with a member of the bone morphogenetic protein (BMP) family, and transmitting a signal across the plasma membrane to initiate a change in cell activity.
|
1 | A0A0B4KG59 (/IDA) |
There are 122 GO terms relating to "biological process"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Activin receptor signaling pathway GO:0032924
A series of molecular signals initiated by the binding of an extracellular ligand to an activin receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
22 |
A0A0B4KG59 (/IMP)
F1NCI7 (/IMP)
P27037 (/IMP)
P27037 (/IMP)
P27037 (/IMP)
P27037 (/IMP)
P27037 (/IMP)
P27037 (/IMP)
P27037 (/IMP)
P27037 (/IMP)
(12 more) |
BMP signaling pathway GO:0030509
A series of molecular signals initiated by the binding of a member of the BMP (bone morphogenetic protein) family to a receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
21 |
A0A0B4KG59 (/IMP)
P27037 (/IMP)
P27037 (/IMP)
P27037 (/IMP)
P27037 (/IMP)
P27037 (/IMP)
P27037 (/IMP)
P27037 (/IMP)
P27037 (/IMP)
P27037 (/IMP)
(11 more) |
BMP signaling pathway GO:0030509
A series of molecular signals initiated by the binding of a member of the BMP (bone morphogenetic protein) family to a receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
17 |
A0A0B4KG59 (/IDA)
P27037 (/IDA)
P27037 (/IDA)
P27037 (/IDA)
P27037 (/IDA)
P27037 (/IDA)
P27037 (/IDA)
P27037 (/IDA)
P27037 (/IDA)
P27037 (/IDA)
(7 more) |
Transmembrane receptor protein serine/threonine kinase signaling pathway GO:0007178
A series of molecular signals initiated by the binding of an extracellular ligand to a receptor on the surface of the target cell where the receptor possesses serine/threonine kinase activity, and ending with regulation of a downstream cellular process, e.g. transcription.
|
16 |
P27037 (/TAS)
P27037 (/TAS)
P27037 (/TAS)
P27037 (/TAS)
P27037 (/TAS)
P27037 (/TAS)
P27037 (/TAS)
P27037 (/TAS)
P27037 (/TAS)
P27037 (/TAS)
(6 more) |
Positive regulation of bone mineralization GO:0030501
Any process that activates or increases the frequency, rate or extent of bone mineralization.
|
16 |
P27037 (/IMP)
P27037 (/IMP)
P27037 (/IMP)
P27037 (/IMP)
P27037 (/IMP)
P27037 (/IMP)
P27037 (/IMP)
P27037 (/IMP)
P27037 (/IMP)
P27037 (/IMP)
(6 more) |
BMP signaling pathway GO:0030509
A series of molecular signals initiated by the binding of a member of the BMP (bone morphogenetic protein) family to a receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
16 |
P27037 (/TAS)
P27037 (/TAS)
P27037 (/TAS)
P27037 (/TAS)
P27037 (/TAS)
P27037 (/TAS)
P27037 (/TAS)
P27037 (/TAS)
P27037 (/TAS)
P27037 (/TAS)
(6 more) |
Positive regulation of activin receptor signaling pathway GO:0032927
Any process that activates or increases the frequency, rate or extent of the activity of any activin receptor signaling pathway.
|
16 |
P27037 (/IDA)
P27037 (/IDA)
P27037 (/IDA)
P27037 (/IDA)
P27037 (/IDA)
P27037 (/IDA)
P27037 (/IDA)
P27037 (/IDA)
P27037 (/IDA)
P27037 (/IDA)
(6 more) |
Positive regulation of osteoblast differentiation GO:0045669
Any process that activates or increases the frequency, rate or extent of osteoblast differentiation.
|
16 |
P27037 (/IMP)
P27037 (/IMP)
P27037 (/IMP)
P27037 (/IMP)
P27037 (/IMP)
P27037 (/IMP)
P27037 (/IMP)
P27037 (/IMP)
P27037 (/IMP)
P27037 (/IMP)
(6 more) |
Positive regulation of protein phosphorylation GO:0001934
Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to amino acids within a protein.
|
14 |
P27037 (/IMP)
P27037 (/IMP)
P27037 (/IMP)
P27037 (/IMP)
P27037 (/IMP)
P27037 (/IMP)
P27037 (/IMP)
P27037 (/IMP)
P27037 (/IMP)
P27037 (/IMP)
(4 more) |
Positive regulation of pathway-restricted SMAD protein phosphorylation GO:0010862
Any process that increases the rate, frequency or extent of pathway-restricted SMAD protein phosphorylation. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways.
|
14 |
P27037 (/IMP)
P27037 (/IMP)
P27037 (/IMP)
P27037 (/IMP)
P27037 (/IMP)
P27037 (/IMP)
P27037 (/IMP)
P27037 (/IMP)
P27037 (/IMP)
P27037 (/IMP)
(4 more) |
Positive regulation of erythrocyte differentiation GO:0045648
Any process that activates or increases the frequency, rate or extent of erythrocyte differentiation.
|
14 |
P27037 (/IDA)
P27037 (/IDA)
P27037 (/IDA)
P27037 (/IDA)
P27037 (/IDA)
P27037 (/IDA)
P27037 (/IDA)
P27037 (/IDA)
P27037 (/IDA)
P27037 (/IDA)
(4 more) |
Positive regulation of transcription by RNA polymerase II GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
|
14 |
P27037 (/IMP)
P27037 (/IMP)
P27037 (/IMP)
P27037 (/IMP)
P27037 (/IMP)
P27037 (/IMP)
P27037 (/IMP)
P27037 (/IMP)
P27037 (/IMP)
P27037 (/IMP)
(4 more) |
Cellular response to BMP stimulus GO:0071773
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a bone morphogenetic protein (BMP) stimulus.
|
14 |
P27037 (/IMP)
P27037 (/IMP)
P27037 (/IMP)
P27037 (/IMP)
P27037 (/IMP)
P27037 (/IMP)
P27037 (/IMP)
P27037 (/IMP)
P27037 (/IMP)
P27037 (/IMP)
(4 more) |
Skeletal system development GO:0001501
The process whose specific outcome is the progression of the skeleton over time, from its formation to the mature structure. The skeleton is the bony framework of the body in vertebrates (endoskeleton) or the hard outer envelope of insects (exoskeleton or dermoskeleton).
|
10 | A9CAY0 (/IMP) A9CAY1 (/IMP) F1Q6M3 (/IMP) F1QG01 (/IMP) F1QLL7 (/IMP) F1R4D0 (/IMP) P27040 (/IMP) Q4V965 (/IMP) Q56E96 (/IMP) Q9YGU4 (/IMP) |
Neural crest cell migration GO:0001755
The characteristic movement of cells from the dorsal ridge of the neural tube to a variety of locations in a vertebrate embryo.
|
9 | A9CAY0 (/IMP) A9CAY1 (/IMP) F1Q6M3 (/IMP) F1QG01 (/IMP) F1QLL7 (/IMP) F1R4D0 (/IMP) Q4V965 (/IMP) Q56E96 (/IMP) Q9YGU4 (/IMP) |
BMP signaling pathway GO:0030509
A series of molecular signals initiated by the binding of a member of the BMP (bone morphogenetic protein) family to a receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
9 | P38444 (/ISS) Q28043 (/ISS) Q28043 (/ISS) Q28043 (/ISS) Q28043 (/ISS) Q28043 (/ISS) Q28043 (/ISS) Q28043 (/ISS) Q28560 (/ISS) |
Hindbrain development GO:0030902
The process whose specific outcome is the progression of the hindbrain over time, from its formation to the mature structure. The hindbrain is the posterior of the three primary divisions of the developing chordate brain, or the corresponding part of the adult brain (in vertebrates, includes the cerebellum, pons, and medulla oblongata and controls the autonomic functions and equilibrium).
|
9 | A9CAY0 (/IMP) A9CAY1 (/IMP) F1Q6M3 (/IMP) F1QG01 (/IMP) F1QLL7 (/IMP) F1R4D0 (/IMP) Q4V965 (/IMP) Q56E96 (/IMP) Q9YGU4 (/IMP) |
Cartilage development GO:0051216
The process whose specific outcome is the progression of a cartilage element over time, from its formation to the mature structure. Cartilage elements are skeletal elements that consist of connective tissue dominated by extracellular matrix containing collagen type II and large amounts of proteoglycan, particularly chondroitin sulfate.
|
9 | A9CAY0 (/IMP) A9CAY1 (/IMP) F1Q6M3 (/IMP) F1QG01 (/IMP) F1QLL7 (/IMP) F1R4D0 (/IMP) Q4V965 (/IMP) Q56E96 (/IMP) Q9YGU4 (/IMP) |
Gastrulation with mouth forming second GO:0001702
A gastrulation process in which the initial invagination becomes the anus and the mouth forms second.
|
5 | P27038 (/IGI) P27038 (/IGI) P27038 (/IGI) P27038 (/IGI) P27040 (/IGI) |
Determination of left/right symmetry GO:0007368
The establishment of an organism's body plan or part of an organism with respect to the left and right halves. The pattern can either be symmetric, such that the halves are mirror images, or asymmetric where the pattern deviates from this symmetry.
|
5 | P27038 (/IGI) P27038 (/IGI) P27038 (/IGI) P27038 (/IGI) P27040 (/IGI) |
Cell population proliferation GO:0008283
The multiplication or reproduction of cells, resulting in the expansion of a cell population.
|
5 | F1NCI7 (/IMP) Q90669 (/IMP) Q90669 (/IMP) Q90669 (/IMP) Q90670 (/IMP) |
Anterior/posterior pattern specification GO:0009952
The regionalization process in which specific areas of cell differentiation are determined along the anterior-posterior axis. The anterior-posterior axis is defined by a line that runs from the head or mouth of an organism to the tail or opposite end of the organism.
|
5 | P27038 (/IGI) P27038 (/IGI) P27038 (/IGI) P27038 (/IGI) P27040 (/IGI) |
Regulation of signal transduction GO:0009966
Any process that modulates the frequency, rate or extent of signal transduction.
|
5 | P27038 (/IDA) P27038 (/IDA) P27038 (/IDA) P27038 (/IDA) P27040 (/IDA) |
Positive regulation of bone mineralization GO:0030501
Any process that activates or increases the frequency, rate or extent of bone mineralization.
|
5 | P27038 (/ISO) P27038 (/ISO) P27038 (/ISO) P27038 (/ISO) P27040 (/ISO) |
BMP signaling pathway GO:0030509
A series of molecular signals initiated by the binding of a member of the BMP (bone morphogenetic protein) family to a receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
5 | P27038 (/ISO) P27038 (/ISO) P27038 (/ISO) P27038 (/ISO) P27040 (/ISO) |
Activin receptor signaling pathway GO:0032924
A series of molecular signals initiated by the binding of an extracellular ligand to an activin receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
5 | P27038 (/ISO) P27038 (/ISO) P27038 (/ISO) P27038 (/ISO) P27040 (/ISO) |
Positive regulation of activin receptor signaling pathway GO:0032927
Any process that activates or increases the frequency, rate or extent of the activity of any activin receptor signaling pathway.
|
5 | P27038 (/ISO) P27038 (/ISO) P27038 (/ISO) P27038 (/ISO) P27040 (/ISO) |
Positive regulation of osteoblast differentiation GO:0045669
Any process that activates or increases the frequency, rate or extent of osteoblast differentiation.
|
5 | P27038 (/ISO) P27038 (/ISO) P27038 (/ISO) P27038 (/ISO) P27040 (/ISO) |
Mesodermal cell differentiation GO:0048333
The process in which a relatively unspecialized cell acquires the specialized features of a mesoderm cell.
|
5 | F1NCI7 (/IMP) Q90669 (/IMP) Q90669 (/IMP) Q90669 (/IMP) Q90670 (/IMP) |
Positive regulation of protein phosphorylation GO:0001934
Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to amino acids within a protein.
|
4 | P27038 (/ISO) P27038 (/ISO) P27038 (/ISO) P27038 (/ISO) |
Spermatogenesis GO:0007283
The process of formation of spermatozoa, including spermatocytogenesis and spermiogenesis.
|
4 | P27038 (/IGI) P27038 (/IGI) P27038 (/IGI) P27038 (/IGI) |
Mesoderm development GO:0007498
The process whose specific outcome is the progression of the mesoderm over time, from its formation to the mature structure. The mesoderm is the middle germ layer that develops into muscle, bone, cartilage, blood and connective tissue.
|
4 | P27038 (/IMP) P27038 (/IMP) P27038 (/IMP) P27038 (/IMP) |
Male gonad development GO:0008584
The process whose specific outcome is the progression of the male gonad over time, from its formation to the mature structure.
|
4 | P27038 (/IMP) P27038 (/IMP) P27038 (/IMP) P27038 (/IMP) |
Axis specification GO:0009798
The establishment, maintenance and elaboration of a pattern along a line or around a point.
|
4 | Q90669 (/IMP) Q90669 (/IMP) Q90669 (/IMP) Q90670 (/IMP) |
Positive regulation of pathway-restricted SMAD protein phosphorylation GO:0010862
Any process that increases the rate, frequency or extent of pathway-restricted SMAD protein phosphorylation. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways.
|
4 | P27038 (/ISO) P27038 (/ISO) P27038 (/ISO) P27038 (/ISO) |
Sperm ejaculation GO:0042713
The expulsion of seminal fluid, thick white fluid containing spermatozoa, from the male genital tract.
|
4 | P27038 (/IMP) P27038 (/IMP) P27038 (/IMP) P27038 (/IMP) |
Penile erection GO:0043084
The hardening, enlarging and rising of the penis which often occurs in the sexually aroused male and enables sexual intercourse. Achieved by increased inflow of blood into the vessels of erectile tissue, and decreased outflow.
|
4 | P27038 (/IMP) P27038 (/IMP) P27038 (/IMP) P27038 (/IMP) |
Positive regulation of erythrocyte differentiation GO:0045648
Any process that activates or increases the frequency, rate or extent of erythrocyte differentiation.
|
4 | P27038 (/ISO) P27038 (/ISO) P27038 (/ISO) P27038 (/ISO) |
Positive regulation of transcription by RNA polymerase II GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
|
4 | P27038 (/ISO) P27038 (/ISO) P27038 (/ISO) P27038 (/ISO) |
Positive regulation of follicle-stimulating hormone secretion GO:0046881
Any process that activates or increases the frequency, rate or extent of the regulated release of follicle-stimulating hormone.
|
4 | P27038 (/ISO) P27038 (/ISO) P27038 (/ISO) P27038 (/ISO) |
Embryonic skeletal system development GO:0048706
The process, occurring during the embryonic phase, whose specific outcome is the progression of the skeleton over time, from its formation to the mature structure.
|
4 | P27038 (/IMP) P27038 (/IMP) P27038 (/IMP) P27038 (/IMP) |
Regulation of nitric-oxide synthase activity GO:0050999
Any process that modulates the activity of the enzyme nitric-oxide synthase.
|
4 | P27038 (/IMP) P27038 (/IMP) P27038 (/IMP) P27038 (/IMP) |
Sertoli cell proliferation GO:0060011
The multiplication or reproduction of Sertoli cells, resulting in the expansion of the Sertoli cell population. A Sertoli cell is a supporting cell projecting inward from the basement membrane of seminiferous tubules.
|
4 | P27038 (/IMP) P27038 (/IMP) P27038 (/IMP) P27038 (/IMP) |
Cellular response to BMP stimulus GO:0071773
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a bone morphogenetic protein (BMP) stimulus.
|
4 | P27038 (/ISO) P27038 (/ISO) P27038 (/ISO) P27038 (/ISO) |
Negative regulation of cold-induced thermogenesis GO:0120163
Any process that stops, prevents, or reduces the rate of cold-induced thermogenesis.
|
4 | A0A0G2JSN4 (/ISS) P38445 (/ISS) Q13705 (/ISS) Q13705 (/ISS) |
Negative regulation of transforming growth factor beta activation GO:1901389
Any process that stops, prevents or reduces the frequency, rate or extent of transforming growth factor beta activation.
|
4 | F1NCI7 (/IMP) K7GLP5 (/IMP) Q66T47 (/IMP) Q90670 (/IMP) |
Compound eye morphogenesis GO:0001745
The morphogenetic process in which the anatomical structures of the compound eye are generated and organized. The adult compound eye is a precise assembly of 700-800 ommatidia. Each ommatidium is composed of 20 cells, identified by cell type and position. An example of compound eye morphogenesis is found in Drosophila melanogaster.
|
3 | A0A0B4KG59 (/NAS) Q24229 (/NAS) Q24468 (/NAS) |
Dorsal closure GO:0007391
The process during Drosophila embryogenesis whereby the ectodermal cells of the lateral epithelium stretch in a coordinated fashion to internalize the amnioserosa cells and close the embryo dorsally.
|
3 | A0A0B4KG59 (/IMP) Q24229 (/IMP) Q24468 (/IMP) |
Dorsal closure GO:0007391
The process during Drosophila embryogenesis whereby the ectodermal cells of the lateral epithelium stretch in a coordinated fashion to internalize the amnioserosa cells and close the embryo dorsally.
|
3 | A0A0B4KG59 (/TAS) Q24229 (/TAS) Q24468 (/TAS) |
Axon guidance GO:0007411
The chemotaxis process that directs the migration of an axon growth cone to a specific target site in response to a combination of attractive and repulsive cues.
|
3 | A0A0B4KG59 (/IMP) Q24229 (/IMP) Q24468 (/IMP) |
Open tracheal system development GO:0007424
The process whose specific outcome is the progression of an open tracheal system over time, from its formation to the mature structure. An open tracheal system is a respiratory system, a branched network of epithelial tubes that supplies oxygen to target tissues via spiracles. An example of this is found in Drosophila melanogaster.
|
3 | A0A0B4KG59 (/IMP) Q24229 (/IMP) Q24468 (/IMP) |
Primary branching, open tracheal system GO:0007428
Formation of primary branches in the open tracheal system. These form from small groups of cells that migrate out at specific positions, organizing into tubes as they migrate. An example of this is found in Drosophila melanogaster.
|
3 | A0A0B4KG59 (/IMP) Q24229 (/IMP) Q24468 (/IMP) |
Malpighian tubule morphogenesis GO:0007443
The process in which the anatomical structures of the Malpighian tubule are generated and organized. This process takes place entirely during the embryonic phase. A Malpighian tubule is a fine, thin-walled excretory tubule in insects which leads into the posterior part of the gut.
|
3 | A0A0B4KG59 (/IMP) Q24229 (/IMP) Q24468 (/IMP) |
Head involution GO:0008258
Movement of the anterior ectoderm to the interior of the embryo.
|
3 | A0A0B4KG59 (/IMP) Q24229 (/IMP) Q24468 (/IMP) |
Anterior/posterior pattern specification GO:0009952
The regionalization process in which specific areas of cell differentiation are determined along the anterior-posterior axis. The anterior-posterior axis is defined by a line that runs from the head or mouth of an organism to the tail or opposite end of the organism.
|
3 | P27040 (/IMP) Q13705 (/IMP) Q13705 (/IMP) |
Germ-line stem cell population maintenance GO:0030718
Any process by which an organism or tissue maintains a population of germ-line stem cells.
|
3 | A0A0B4KG59 (/IMP) Q24229 (/IMP) Q24468 (/IMP) |
Germ-line stem cell division GO:0042078
The self-renewing division of a germline stem cell to produce a daughter stem cell and a daughter germ cell, which will divide to form the gametes.
|
3 | A0A0B4KG59 (/IMP) Q24229 (/IMP) Q24468 (/IMP) |
Negative regulation of salivary gland boundary specification GO:0045705
Any process that stops, prevents, or reduces the frequency, rate or extent of salivary gland determination.
|
3 | A0A0B4KG59 (/TAS) Q24229 (/TAS) Q24468 (/TAS) |
Neuron development GO:0048666
The process whose specific outcome is the progression of a neuron over time, from initial commitment of the cell to a specific fate, to the fully functional differentiated cell.
|
3 | A0A0B4KG59 (/IMP) Q24229 (/IMP) Q24468 (/IMP) |
Dendrite morphogenesis GO:0048813
The process in which the anatomical structures of a dendrite are generated and organized.
|
3 | A0A0B4KG59 (/NAS) Q24229 (/NAS) Q24468 (/NAS) |
Negative regulation of transcription by RNA polymerase II GO:0000122
Any process that stops, prevents, or reduces the frequency, rate or extent of transcription mediated by RNA polymerase II.
|
2 | Q13705 (/IGI) Q13705 (/IGI) |
Lymphangiogenesis GO:0001946
Lymph vessel formation when new vessels emerge from the proliferation of pre-existing vessels.
|
2 | Q13705 (/ISS) Q13705 (/ISS) |
Blood vessel remodeling GO:0001974
The reorganization or renovation of existing blood vessels.
|
2 | Q13705 (/ISS) Q13705 (/ISS) |
Regulation of transcription, DNA-templated GO:0006355
Any process that modulates the frequency, rate or extent of cellular DNA-templated transcription.
|
2 | Q13705 (/IDA) Q13705 (/IDA) |
Protein phosphorylation GO:0006468
The process of introducing a phosphate group on to a protein.
|
2 | P38444 (/TAS) P38445 (/TAS) |
Signal transduction GO:0007165
The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.
|
2 | Q13705 (/IDA) Q13705 (/IDA) |
Adrenal gland development GO:0030325
The process whose specific outcome is the progression of the adrenal gland over time, from its formation to the mature structure. This gland can either be a discrete structure located bilaterally above each kidney, or a cluster of cells in the head kidney that perform the functions of the adrenal gland. In either case, this organ consists of two cells types, aminergic chromaffin cells and steroidogenic cortical cells.
|
2 | P38444 (/IEP) P38445 (/IEP) |
Positive regulation of neuron apoptotic process GO:0043525
Any process that activates or increases the frequency, rate or extent of cell death of neurons by apoptotic process.
|
2 | F1NCI7 (/IMP) Q90670 (/IMP) |
Lymphatic endothelial cell differentiation GO:0060836
The process in which a venous blood vessel endothelial cell acquires specialized features of a lymphatic vessel endothelial cell, a thin flattened cell that lines the inside surfaces of lymph vessels.
|
2 | Q13705 (/ISS) Q13705 (/ISS) |
Artery development GO:0060840
The progression of the artery over time, from its initial formation to the mature structure. An artery is a blood vessel that carries blood away from the heart to a capillary bed.
|
2 | Q13705 (/ISS) Q13705 (/ISS) |
Venous blood vessel development GO:0060841
The progression of the venous blood vessel over time from its initial formation to the mature structure. Venous blood vessels carry blood back to the heart after the capillary bed.
|
2 | Q13705 (/ISS) Q13705 (/ISS) |
Retina vasculature development in camera-type eye GO:0061298
The process whose specific outcome is the progression of the vasculature of the retina over time, from its formation to the mature structure.
|
2 | Q13705 (/ISS) Q13705 (/ISS) |
Cranial ganglion development GO:0061550
The process whose specific outcome is the progression of a cranial ganglion over time, from its formation to the mature structure.
|
2 | F1NCI7 (/IMP) Q90670 (/IMP) |
Negative regulation of transcription by RNA polymerase II GO:0000122
Any process that stops, prevents, or reduces the frequency, rate or extent of transcription mediated by RNA polymerase II.
|
1 | P27040 (/ISO) |
Skeletal system development GO:0001501
The process whose specific outcome is the progression of the skeleton over time, from its formation to the mature structure. The skeleton is the bony framework of the body in vertebrates (endoskeleton) or the hard outer envelope of insects (exoskeleton or dermoskeleton).
|
1 | P27040 (/IGI) |
Kidney development GO:0001822
The process whose specific outcome is the progression of the kidney over time, from its formation to the mature structure. The kidney is an organ that filters the blood and/or excretes the end products of body metabolism in the form of urine.
|
1 | P27040 (/IGI) |
Kidney development GO:0001822
The process whose specific outcome is the progression of the kidney over time, from its formation to the mature structure. The kidney is an organ that filters the blood and/or excretes the end products of body metabolism in the form of urine.
|
1 | P27040 (/IMP) |
Lymphangiogenesis GO:0001946
Lymph vessel formation when new vessels emerge from the proliferation of pre-existing vessels.
|
1 | P27040 (/IMP) |
Blood vessel remodeling GO:0001974
The reorganization or renovation of existing blood vessels.
|
1 | P27040 (/IMP) |
Regulation of transcription, DNA-templated GO:0006355
Any process that modulates the frequency, rate or extent of cellular DNA-templated transcription.
|
1 | P27040 (/ISO) |
Signal transduction GO:0007165
The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.
|
1 | P27040 (/ISO) |
Determination of left/right symmetry GO:0007368
The establishment of an organism's body plan or part of an organism with respect to the left and right halves. The pattern can either be symmetric, such that the halves are mirror images, or asymmetric where the pattern deviates from this symmetry.
|
1 | P27040 (/IMP) |
Pattern specification process GO:0007389
Any developmental process that results in the creation of defined areas or spaces within an organism to which cells respond and eventually are instructed to differentiate.
|
1 | P27040 (/IGI) |
Imaginal disc-derived wing morphogenesis GO:0007476
The process in which the anatomical structures of the imaginal disc-derived wing are generated and organized. The wing is an appendage modified for flying.
|
1 | A0A0B4KG59 (/IGI) |
Mesoderm development GO:0007498
The process whose specific outcome is the progression of the mesoderm over time, from its formation to the mature structure. The mesoderm is the middle germ layer that develops into muscle, bone, cartilage, blood and connective tissue.
|
1 | P27040 (/IGI) |
Heart development GO:0007507
The process whose specific outcome is the progression of the heart over time, from its formation to the mature structure. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood.
|
1 | P27040 (/IGI) |
Heart development GO:0007507
The process whose specific outcome is the progression of the heart over time, from its formation to the mature structure. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood.
|
1 | P27040 (/IMP) |
Response to glucose GO:0009749
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucose stimulus.
|
1 | P27040 (/IGI) |
Post-embryonic development GO:0009791
The process whose specific outcome is the progression of the organism over time, from the completion of embryonic development to the mature structure. See embryonic development.
|
1 | P27040 (/IGI) |
Post-embryonic development GO:0009791
The process whose specific outcome is the progression of the organism over time, from the completion of embryonic development to the mature structure. See embryonic development.
|
1 | P27040 (/IMP) |
Anterior/posterior pattern specification GO:0009952
The regionalization process in which specific areas of cell differentiation are determined along the anterior-posterior axis. The anterior-posterior axis is defined by a line that runs from the head or mouth of an organism to the tail or opposite end of the organism.
|
1 | P27040 (/ISO) |
Dorsal/ventral pattern formation GO:0009953
The regionalization process in which the areas along the dorsal/ventral axis are established that will lead to differences in cell differentiation. The dorsal/ventral axis is defined by a line that runs orthogonal to both the anterior/posterior and left/right axes. The dorsal end is defined by the upper or back side of an organism. The ventral end is defined by the lower or front side of an organism.
|
1 | A0A0B4KG59 (/IGI) |
Dorsal/ventral pattern formation GO:0009953
The regionalization process in which the areas along the dorsal/ventral axis are established that will lead to differences in cell differentiation. The dorsal/ventral axis is defined by a line that runs orthogonal to both the anterior/posterior and left/right axes. The dorsal end is defined by the upper or back side of an organism. The ventral end is defined by the lower or front side of an organism.
|
1 | A0A0B4KG59 (/IMP) |
Response to organic substance GO:0010033
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic substance stimulus.
|
1 | P38444 (/IEP) |
Sexual reproduction GO:0019953
A reproduction process that creates a new organism by combining the genetic material of two gametes, which may come from two organisms or from a single organism, in the case of self-fertilizing hermaphrodites, e.g. C. elegans, or self-fertilization in plants. It occurs both in eukaryotes and prokaryotes: in multicellular eukaryotic organisms, an individual is created anew; in prokaryotes, the initial cell has additional or transformed genetic material. In a process called genetic recombination, genetic material (DNA) originating from two gametes join up so that homologous sequences are aligned with each other, and this is followed by exchange of genetic information. After the new recombinant chromosome is formed, it is passed on to progeny.
|
1 | P38445 (/NAS) |
Insulin secretion GO:0030073
The regulated release of proinsulin from secretory granules accompanied by cleavage of proinsulin to form mature insulin. In vertebrates, insulin is secreted from B granules in the B cells of the vertebrate pancreas and from insulin-producing cells in insects.
|
1 | P27040 (/IGI) |
Lung development GO:0030324
The process whose specific outcome is the progression of the lung over time, from its formation to the mature structure. In all air-breathing vertebrates the lungs are developed from the ventral wall of the oesophagus as a pouch which divides into two sacs. In amphibians and many reptiles the lungs retain very nearly this primitive sac-like character, but in the higher forms the connection with the esophagus becomes elongated into the windpipe and the inner walls of the sacs become more and more divided, until, in the mammals, the air spaces become minutely divided into tubes ending in small air cells, in the walls of which the blood circulates in a fine network of capillaries. In mammals the lungs are more or less divided into lobes, and each lung occupies a separate cavity in the thorax.
|
1 | P27040 (/IGI) |
BMP signaling pathway GO:0030509
A series of molecular signals initiated by the binding of a member of the BMP (bone morphogenetic protein) family to a receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
1 | A0A0B4KG59 (/IGI) |
Pancreas development GO:0031016
The process whose specific outcome is the progression of the pancreas over time, from its formation to the mature structure. The pancreas is an endoderm derived structure that produces precursors of digestive enzymes and blood glucose regulating enzymes.
|
1 | P27040 (/IGI) |
Activation of protein kinase activity GO:0032147
Any process that initiates the activity of an inactive protein kinase.
|
1 | P27040 (/IDA) |
Activin receptor signaling pathway GO:0032924
A series of molecular signals initiated by the binding of an extracellular ligand to an activin receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
1 | A0A0B4KG59 (/IDA) |
Activin receptor signaling pathway GO:0032924
A series of molecular signals initiated by the binding of an extracellular ligand to an activin receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
1 | A0A0B4KG59 (/IGI) |
Wing disc pattern formation GO:0035222
The process giving rise to the pattern of cell differentiation in the wing imaginal disc.
|
1 | A0A0B4KG59 (/IMP) |
Organ growth GO:0035265
The increase in size or mass of an organ. Organs are commonly observed as visibly distinct structures, but may also exist as loosely associated clusters of cells that function together as to perform a specific function.
|
1 | P27040 (/IGI) |
Odontogenesis of dentin-containing tooth GO:0042475
The process whose specific outcome is the progression of a dentin-containing tooth over time, from its formation to the mature structure. A dentin-containing tooth is a hard, bony organ borne on the jaw or other bone of a vertebrate, and is composed mainly of dentin, a dense calcified substance, covered by a layer of enamel.
|
1 | P27040 (/IGI) |
Odontogenesis of dentin-containing tooth GO:0042475
The process whose specific outcome is the progression of a dentin-containing tooth over time, from its formation to the mature structure. A dentin-containing tooth is a hard, bony organ borne on the jaw or other bone of a vertebrate, and is composed mainly of dentin, a dense calcified substance, covered by a layer of enamel.
|
1 | P27040 (/IMP) |
Glucose homeostasis GO:0042593
Any process involved in the maintenance of an internal steady state of glucose within an organism or cell.
|
1 | A0A0B4KG59 (/IMP) |
R8 cell fate specification GO:0045464
The process in which a cell becomes capable of differentiating autonomously into an R8 cell in an environment that is neutral with respect to the developmental pathway; upon specification, the cell fate can be reversed.
|
1 | A0A0B4KG59 (/IMP) |
Positive regulation of follicle-stimulating hormone secretion GO:0046881
Any process that activates or increases the frequency, rate or extent of the regulated release of follicle-stimulating hormone.
|
1 | P38444 (/IMP) |
Embryonic foregut morphogenesis GO:0048617
The process in which the anatomical structures of the foregut are generated and organized, during the embryonic phase.
|
1 | P27040 (/IMP) |
Skeletal system morphogenesis GO:0048705
The process in which the anatomical structures of the skeleton are generated and organized.
|
1 | P27040 (/IGI) |
Skeletal system morphogenesis GO:0048705
The process in which the anatomical structures of the skeleton are generated and organized.
|
1 | P27040 (/IMP) |
Roof of mouth development GO:0060021
The biological process whose specific outcome is the progression of the roof of the mouth from an initial condition to its mature state. This process begins with the formation of the structure and ends with the mature structure. The roof of the mouth is the partition that separates the nasal and oral cavities.
|
1 | P27040 (/IGI) |
Roof of mouth development GO:0060021
The biological process whose specific outcome is the progression of the roof of the mouth from an initial condition to its mature state. This process begins with the formation of the structure and ends with the mature structure. The roof of the mouth is the partition that separates the nasal and oral cavities.
|
1 | P27040 (/IMP) |
Positive regulation of SMAD protein signal transduction GO:0060391
Any process that increases the rate, frequency or extent of SMAD protein signal transduction. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways.
|
1 | A0A0B4KG59 (/IDA) |
Lymphatic endothelial cell differentiation GO:0060836
The process in which a venous blood vessel endothelial cell acquires specialized features of a lymphatic vessel endothelial cell, a thin flattened cell that lines the inside surfaces of lymph vessels.
|
1 | P27040 (/IMP) |
Artery development GO:0060840
The progression of the artery over time, from its initial formation to the mature structure. An artery is a blood vessel that carries blood away from the heart to a capillary bed.
|
1 | P27040 (/IMP) |
Venous blood vessel development GO:0060841
The progression of the venous blood vessel over time from its initial formation to the mature structure. Venous blood vessels carry blood back to the heart after the capillary bed.
|
1 | P27040 (/IMP) |
Retina vasculature development in camera-type eye GO:0061298
The process whose specific outcome is the progression of the vasculature of the retina over time, from its formation to the mature structure.
|
1 | P27040 (/IMP) |
Cellular response to glucose stimulus GO:0071333
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucose stimulus.
|
1 | A0A0B4KG59 (/IMP) |
Negative regulation of cold-induced thermogenesis GO:0120163
Any process that stops, prevents, or reduces the rate of cold-induced thermogenesis.
|
1 | P27040 (/IMP) |
Positive regulation of neuromuscular junction development GO:1904398
Any process that activates or increases the frequency, rate or extent of neuromuscular junction development.
|
1 | A0A0B4KG59 (/IMP) |
There are 16 GO terms relating to "cellular component"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
|
21 |
P27037 (/TAS)
P27037 (/TAS)
P27037 (/TAS)
P27037 (/TAS)
P27037 (/TAS)
P27037 (/TAS)
P27037 (/TAS)
P27037 (/TAS)
P27037 (/TAS)
P27037 (/TAS)
(11 more) |
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
19 |
P27037 (/IDA)
P27037 (/IDA)
P27037 (/IDA)
P27037 (/IDA)
P27037 (/IDA)
P27037 (/IDA)
P27037 (/IDA)
P27037 (/IDA)
P27037 (/IDA)
P27037 (/IDA)
(9 more) |
Integral component of plasma membrane GO:0005887
The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
|
16 |
P27037 (/TAS)
P27037 (/TAS)
P27037 (/TAS)
P27037 (/TAS)
P27037 (/TAS)
P27037 (/TAS)
P27037 (/TAS)
P27037 (/TAS)
P27037 (/TAS)
P27037 (/TAS)
(6 more) |
Receptor complex GO:0043235
Any protein complex that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
|
16 |
P27037 (/IPI)
P27037 (/IPI)
P27037 (/IPI)
P27037 (/IPI)
P27037 (/IPI)
P27037 (/IPI)
P27037 (/IPI)
P27037 (/IPI)
P27037 (/IPI)
P27037 (/IPI)
(6 more) |
Inhibin-betaglycan-ActRII complex GO:0034673
A protein complex that consists of inhibin, type III transforming growth factor beta receptor (also known as betaglycan), and the type II activin receptor ActRII. The complex is thought to negatively regulate the activity of activin B.
|
14 |
P27037 (/IDA)
P27037 (/IDA)
P27037 (/IDA)
P27037 (/IDA)
P27037 (/IDA)
P27037 (/IDA)
P27037 (/IDA)
P27037 (/IDA)
P27037 (/IDA)
P27037 (/IDA)
(4 more) |
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
5 | P27038 (/ISO) P27038 (/ISO) P27038 (/ISO) P27038 (/ISO) P27040 (/ISO) |
Receptor complex GO:0043235
Any protein complex that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
|
5 | P27038 (/ISO) P27038 (/ISO) P27038 (/ISO) P27038 (/ISO) P27040 (/ISO) |
Cell surface GO:0009986
The external part of the cell wall and/or plasma membrane.
|
4 | P27038 (/IDA) P27038 (/IDA) P27038 (/IDA) P27038 (/IDA) |
Inhibin-betaglycan-ActRII complex GO:0034673
A protein complex that consists of inhibin, type III transforming growth factor beta receptor (also known as betaglycan), and the type II activin receptor ActRII. The complex is thought to negatively regulate the activity of activin B.
|
4 | P27038 (/ISO) P27038 (/ISO) P27038 (/ISO) P27038 (/ISO) |
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
|
3 | A0A0B4KG59 (/ISM) Q24229 (/ISM) Q24468 (/ISM) |
Membrane GO:0016020
A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
|
3 | Q90669 (/IDA) Q90669 (/IDA) Q90669 (/IDA) |
Activin receptor complex GO:0048179
A protein complex that acts as an activin receptor. Heterodimeric activin receptors, comprising one Type I activin receptor and one Type II receptor polypeptide, and heterotrimeric receptors have been observed.
|
3 | A0A0B4KG59 (/IPI) Q24229 (/IPI) Q24468 (/IPI) |
Protein-containing complex GO:0032991
A stable assembly of two or more macromolecules, i.e. proteins, nucleic acids, carbohydrates or lipids, in which at least one component is a protein and the constituent parts function together.
|
2 | Q13705 (/IDA) Q13705 (/IDA) |
Basal part of cell GO:0045178
The region of a cell situated near the base. For example, in a polarized epithelial cell, the basal surface rests on the basal lamina that separates the epithelium from other tissue.
|
2 | F1NCI7 (/IDA) Q90670 (/IDA) |
Protein-containing complex GO:0032991
A stable assembly of two or more macromolecules, i.e. proteins, nucleic acids, carbohydrates or lipids, in which at least one component is a protein and the constituent parts function together.
|
1 | P27040 (/ISO) |
BMP receptor complex GO:0070724
A protein complex that acts as a receptor for bone morphogenetic proteins (BMPs); a homo- or heterodimer of type I and/or type II BMP receptor subunits.
|
1 | A0A0B4KG59 (/IPI) |